Renalis

renalis.health

Renalis develops FDA-cleared prescription digital therapeutics specifically for pelvic health disorders, focusing on delivering evidence-based therapeutic interventions through software applications. Their flagship product, Ce Ce, is a mobile-enhanced digital therapeutic designed for the first-line treatment of overactive bladder (OAB) in individuals assigned female at birth. By providing cost-effective and engaging behavioral therapy via smartphones, Renalis aims to improve patient outcomes and experiences in pelvic health management. The company is positioned in the digital health market, leveraging clinical trials and FDA clearance to ensure the efficacy and safety of their products.